Cellular FLICE-inhibitory protein regulates chemotherapy-induced apoptosis in breast cancer cells

Combination treatment regimens that include topoisomerase-II–targeted drugs, such as doxorubicin, are widely used in the treatment of breast cancer. Previously, we showed that IFN-γ and doxorubicin cotreatment synergistically induced apoptosis in MDA435 breast cancer cells in a signal transducer and activator of transcription 1–dependent manner. In this study, we found that this synergy was caspase-8 dependent. In addition, we found that IFN-γ down-regulated the expression of the caspase-8 inhibitor cellular FLICE-inhibitory protein (c-FLIP). Furthermore, IFN-γ down-regulated c-FLIP in a manner that was dependent on the transcription factors signal transducer and activator of transcription 1 and IFN regulatory factor-1. However, IFN-γ had no effect on c-FLIP mRNA levels, indicating that c-FLIP was down-regulated at a posttranscriptional level following IFN-γ treatment. Characterization of the functional significance of c-FLIP modulation by small interfering RNA gene silencing and stable overexpression studies revealed it to be a key regulator of IFN-γ– and doxorubicin-induced apoptosis in MDA435 cells. Analysis of a panel of breast cancer cell lines indicated that c-FLIP was an important general determinant of doxorubicin- and IFN-γ–induced apoptosis in breast cancer cells. Furthermore, c-FLIP gene silencing sensitized MDA435 cells to other chemotherapies, including etoposide, mitoxantrone, and SN-38. These results suggest that c-FLIP plays a pivotal role in modulating drug-induced apoptosis in breast cancer cells. [Mol Cancer Ther 2007;6(5):1544–51]

[1]  S. Fulda,et al.  Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. , 2000, Cancer research.

[2]  R. Budd.  Death receptors couple to both cell proliferation and apoptosis. , 2002, The Journal of clinical investigation.

[3]  R. Knight,et al.  Induction of Apoptosis and Fas Receptor/Fas Ligand Expression by Ischemia/Reperfusion in Cardiac Myocytes Requires Serine 727 of the STAT-1 Transcription Factor but Not Tyrosine 701* , 2001, The Journal of Biological Chemistry.

[4]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[5]  L. Espert,et al.  Interferons α and γ induce p53-dependent and p53-independent apoptosis, respectively , 2005, Oncogene.

[6]  T. Wilson,et al.  Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP , 2005, Molecular Cancer Therapeutics.

[7]  S. Fulda,et al.  IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway , 2002, Oncogene.

[8]  W L Allen,et al.  c-FLIP inhibits chemotherapy-induced colorectal cancer cell death , 2006, Oncogene.

[9]  M. Sporn,et al.  An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[10]  P. Johnston,et al.  STAT1: a modulator of chemotherapy-induced apoptosis. , 2004, Cancer research.

[11]  D. Aaronson,et al.  A Road Map for Those Who Don't Know JAK-STAT , 2002, Science.

[12]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[13]  K. Pelin,et al.  Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines. , 1992, Anti-cancer drugs.

[14]  A. López-Rivas,et al.  Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells. , 2002, The Biochemical journal.

[15]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[16]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[17]  P. Johnston,et al.  Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. , 1993, Advances in experimental medicine and biology.

[18]  J. Turkson,et al.  STAT proteins: novel molecular targets for cancer drug discovery , 2000, Oncogene.

[19]  S. Pestka,et al.  The interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor , 1997 .

[20]  Ingo Schmitz,et al.  The Role of c-FLIP in Modulation of CD95-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[21]  V. Dixit,et al.  Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.

[22]  A. López-Rivas,et al.  Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program. , 2000, Cancer research.

[23]  B. Williams,et al.  Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis , 2003, Apoptosis.

[24]  Williams,et al.  Identification of genes differentially regulated by interferon a , b , or g using oligonucleotide arrays , 1998 .

[25]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.

[26]  G. Hortobagyi,et al.  Chemotherapy: what progress in the last 5 years? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[28]  Kangsheng Wang,et al.  Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. , 2000, Analytical biochemistry.

[29]  K. Kohn,et al.  Apoptosis induced by topoisomerase inhibitors. , 2003, Current medicinal chemistry. Anti-cancer agents.

[30]  M. Smyth,et al.  TRAIL and its receptors as targets for cancer therapy , 2004, Cancer science.

[31]  A. López-Rivas,et al.  Interferon-γ Sensitizes Human Myeloid Leukemia Cells to Death Receptor-mediated Apoptosis by a Pleiotropic Mechanism* , 2001, The Journal of Biological Chemistry.

[32]  P. Krammer,et al.  FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis , 2001, Molecular and Cellular Biology.

[33]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[34]  F. Monti,et al.  Synergism between gamma interferon and doxorubicin in a human MDR colon adenocarcinoma cell line. , 1994, Journal of chemotherapy.